Stock AnalizQiagen NV (QGEN) earnings for the quarter ended September 2026: EPS beats estimates
Qiagen NV reported results for the quarter ended September 2026 on November 4, 2026. Adjusted earnings per share came in at $0.65 against the analysts’ average forecast of $0.63, a beat of 3.6%.
The market’s verdict: the stock rose 0.9% on the first trading day after the report.
The last four quarters
Qiagen NV has beaten the analysts’ EPS forecast in 2 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $0.65 | $0.63 | +3.6% | — | +0.9% |
| Jun 2026 | $0.62 | $0.60 | +3.5% | — | −1.4% |
| Mar 2026 | $0.54 | $0.54 | +0.0% | — | −1.4% |
| Dec 2025 | $0.62 | $0.62 | +0.1% | — | −1.3% |
What comes next
Analysts expect EPS of $0.68 for the next quarter on average and $2.49 for the fiscal year ending December 31, 2026.
The average analyst price target is $49.59, 1% below the current price of $49.89.
Valuation and score
Qiagen NV scores 2.0 out of 5 overall on Stock Analiz (average), trades at a trailing P/E of about 27.0, and its intrinsic value under moderate assumptions is about 37% below the current market value. Full Qiagen NV analysis with 10 years of financials
Frequently asked questions
What was Qiagen NV’s EPS for the quarter ended September 2026?
$0.65 adjusted per share, against an analyst consensus of $0.63.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.